Assessement of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4311-4316

  Kakolyris, S ^a   Giatromanolaki, A ^a   Koukourakis, M ^a   Kaklamanis, L ^a   Kouroussis, Ch ^a   Bozionelou, V ^a   Georgoulias, V ^a   Gatter, K C ^a   Harris, A L ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Angiogenesis; Breast cancer; NSCLC; Prognosis; Vascular maturation

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LH39; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN A;

ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CELL MATURATION; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; BREAST TUMOR; IMMUNOLOGY; LUNG TUMOR; METABOLISM; VASCULARIZATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; BASEMENT MEMBRANE; BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035528957     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Vasculogenesis
2. Endothelial proliferation in tumors and normal tissues: Continuous labeling studies
3. Tumor angiogenesis
4. The vascular morphology of tumors
5. First steps of tumor-related angiogenesis
6. Tumor-related angiogenesis
7. Prognostic value of angiogenesis in mammary tumors
8. Demonstration and characterization of the angiogenic properties of cervical dysplasia
9. Relation of neovascularization to metastases of non-small cell lung cancer
10. Independent prognostic significance of microvessel density in clinically localized prostate cancer
11. Expression of Thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer
12. Thymidine phosphorylase expression in gastric cancer in association with proliferative activity and angiogenesis
13. Tumor angiogenesis as a prognostic factor in oral cavity tumors
14. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
15. Basement membrane nomenclature
16. The basement membrane
17. The basement membrane in pathology
18. Structure and biological activity of basement membrane proteins
19. A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody
20. The distribution of LH39 basement membrane epitope in the tumor stroma of oral squamous cell carcinomas
21. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
22. Assessement of vascular maturation in NSCLC using a novel basement membrane component, LH39. Correlation with p53 and angiogenic factor expression
23. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
24. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
25. New perspectives in clinical oncology from angiogenesis research
26. Angiogenic activity of enzymes
27. Thymidine phosphorylase is angiogenic and promotes tumor growth
28. p53 in tumor pathology: Can we trust immunohistochemistry? -Revisited
29. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
30. Correlation of intratumoral endothelial-cell proliferation with microvessel density (tumor angiogenesis) and tumor-cell proliferation in breast-carcinoma
31. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in murine model
32. Oestrogen and endothelial cell angiogenic activity
33. Effects of 17β-estradiol on cytokine induced endothelial cell adhesion molecule expression
34. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
35. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man
36. Microvascular structure of benign and malignant disease of the colon in humans
37. Angiogenesis in primary lung cancer and lung secondaries
38. The prognostic value of tumor blood vessel morphology in primary uveal melanoma
39. Tumor angiogenesis and prognosis
40. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
41. Inhibition of basement membrane biosynthesis prevents angiogenesis
42. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide
43. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSRNH2
44. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: An in vivo Matrigel model
45. The role of basement membrane in angiogenesis and tumor growth
46. Inhibition of angiogenesis through modulation of collagen metabolism